Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALB | P02768 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18963575 | 1.00 | ALDH1A1 (0.55) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL21392956 | 0.93 | KDM4E (0.62) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL1697216 | 0.93 | KDM4E (0.62) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL22990581 | 0.93 | KDM4E (0.62) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL3484940 | 0.93 | KDM4E (0.62) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL21393208 | 0.87 | KDM4E (0.58) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL21393002 | 0.86 | TAS1R3 (0.48) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL27093012 | 0.85 | ALDH1A1 (0.63) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL21393042 | 0.84 | KDM4E (0.57) | ALDH1A1LMNAALBMAPK1KDM4E | |
| SCHEMBL26196576 | 0.84 | KDM4E (0.57) | ALDH1A1LMNAALBMAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3922637-A1 | MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES | Janssen Pharmaceutica NV (BE) | 2021-12-15 | — | — | EP | disclosed |
| WO-2019175260-A2 | MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE IN TAUOPATHIES | JANSSEN PHARMACEUTICA NV (BE) | 2019-09-19 | — | — | WO | disclosed |